Figure 4. The gene signature from moduleS3 predicts clinical outcome of glioma datasets from GEO.

The glioma datasets were respectively extracted from the studies of (A) Freije et al., (B) Phillips et al., (C) Murat et al., and (D) Lee et al.. The significance of clinical outcome difference between the low-risk and high-risk groups was estimated by K-M survival analysis. P-values were calculated by the log-rank test.